Rubifen (methylphenidate)

References

1. Brand–generic pairings reflect products commonly encountered in SA scripts; confirm current SAHPRA registration on the label or package insert.
   SAHPRA; MIMS / SA package inserts
2. Strength list shows unit doses commonly available in SA tablets, capsules, inhalers, or injections — verify against the dispensed product.
   MIMS / SA package inserts; SA Essential Medicines List (EML); ClaimBuddy curated
3. Typical dosing is a general SA prescribing range for claims context only — actual dose must match the treating clinician's script.
   MIMS / SA package inserts; ClaimBuddy curated
4. IR, LA, and ER methylphenidate formulations differ in onset, duration, and titration — document the exact brand and strength on your script for claims evidence.
   SAHPRA; MIMS / SA package inserts; ClaimBuddy curated

Data sources

Verify against your script, package insert, and treating clinician.

• WHO ICD-10 — Condition names and ICD-10-CM codes in the condition index.
• SAHPRA — South African medicine registration context; brand products must be SAHPRA-registered to be dispensed.
• MIMS / SA package inserts — Registered strengths, formulations, and typical dosing ranges for SA market products.
• SA Essential Medicines List (EML) — Public-sector formulary context for commonly available strengths.
• ClaimBuddy curated — SA brand name collation from intake presets, claim-frequency mapping, and work-impact notes — not a substitute for prescribing information.